Latest Lead News

Recce Pharmaceuticals has secured a significant patent acceptance in China for its RECCE® anti-infectives, broadening its intellectual property footprint in the world’s second-largest pharmaceutical market.

OncoSil Medical has launched a $8.7 million capital raising via a Share Purchase Plan and Placement, seeking shareholder approval for options issuance and a 400:1 share consolidation.

Jameson Resources has raised A$3.5 million through a two-tranche placement to fund environmental approvals and Indigenous engagement for its Crown Mountain Hard Coking Coal Project in Canada.

Surefire Resources NL has launched a non-renounceable entitlement offer aiming to raise approximately A$3.87 million to advance its gold and copper projects in Western Australia. The offer includes new shares, bonus shares, and options, targeting eligible shareholders in Australia and New Zealand.

Surefire Resources NL has announced a non-renounceable pro-rata entitlement offer to raise approximately $3.88 million, including free attaching bonus shares and options, aimed at advancing its key gold and copper projects in Western Australia.

Veris Limited has secured over $2 million in new digital project contracts, reinforcing its leadership in spatial data consulting across energy, transport, and government sectors. These wins highlight the company’s innovative use of proprietary platforms and advanced data capture technologies.

4DMedical has submitted its CT:VQ™ software to the FDA, aiming to revolutionize lung ventilation and perfusion imaging by replacing traditional nuclear scans with a non-contrast CT-based solution.

Viva Leisure has taken a strategic 33% stake in Gorilla X Labs, aiming to deepen its footprint in the sports nutrition market and enhance member offerings across its platforms.

New World Resources’ Antler Copper Project in Arizona has been designated a FAST-41 Transparency Project, promising a streamlined federal permitting process and reinforcing its strategic role in US critical minerals supply.

TruScreen Group Limited reported a 19% revenue decline in FY2025 due to delayed rollouts in key emerging markets but anticipates a strong rebound with FY2026 sales forecast to exceed NZ$2.8 million.

Rhythm Biosciences has successfully validated its second-generation ColoSTAT® Beta assay, confirming its readiness for commercial application in colorectal cancer detection. The Beta kit offers improved precision and faster turnaround times compared to its predecessor.

Canyon Resources has locked in a US$140 million syndicated credit facility alongside a AU$24.5 million option exercise by a major shareholder, positioning the company to fast-track operations at its Minim Martap Bauxite Project in Cameroon.